Publication: Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group
| dc.contributor.author | Samosorn S. | |
| dc.contributor.author | Tanwirat B. | |
| dc.contributor.author | Muhamad N. | |
| dc.contributor.author | Casadei G. | |
| dc.contributor.author | Tomkiewicz D. | |
| dc.contributor.author | Lewis K. | |
| dc.contributor.author | Suksamrarn A. | |
| dc.contributor.author | Prammananan T. | |
| dc.contributor.author | Gornall K.C. | |
| dc.contributor.author | Beck J.L. | |
| dc.contributor.author | Bremner J.B. | |
| dc.date.accessioned | 2021-04-05T04:32:50Z | |
| dc.date.available | 2021-04-05T04:32:50Z | |
| dc.date.issued | 2009 | |
| dc.date.issuedBE | 2552 | |
| dc.description.abstract | Conjugation of the NorA substrate berberine and the NorA inhibitor 5-nitro-2-phenyl-1H-indole via a methylene ether linking group gave the 13-substituted berberine-NorA inhibitor hybrid, 3. A series of simpler arylmethyl ether hybrid structures were also synthesized. The hybrid 3 showed excellent antibacterial activity (MIC Staphylococcus aureus, 1.7 μM), which was over 382-fold more active than the parent antibacterial berberine, against this bacterium. This compound was also shown to block the NorA efflux pump in S. aureus. © 2009 Elsevier Ltd. | |
| dc.format.mimetype | application/pdf | |
| dc.identifier.citation | Bioorganic and Medicinal Chemistry. Vol 17, No.11 (2009), p.3866-3872 | |
| dc.identifier.doi | 10.1016/j.bmc.2009.04.028 | |
| dc.identifier.issn | 9680896 | |
| dc.identifier.other | 2-s2.0-65549100031 | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14740/6519 | |
| dc.rights.holder | Scopus | |
| dc.subject.other | 5 nitro 2 phenyl 1h indole | |
| dc.subject.other | 9,10 dimethoxy 13 [2 (5 nitro 1h indol 2 yl)benzyloxy] 5,6 dihydrobenzo[g] 1,3 benzodioxolo[5,6 a]quinolizinium bromide | |
| dc.subject.other | Berberine | |
| dc.subject.other | Berberine 5 nitro 2 phenyl 1h indole conjugate | |
| dc.subject.other | Inf 55 | |
| dc.subject.other | NorA pump inhibitor | |
| dc.subject.other | Protein inhibitor | |
| dc.subject.other | Unclassified drug | |
| dc.subject.other | Antibacterial activity | |
| dc.subject.other | Article | |
| dc.subject.other | Bacterial strain | |
| dc.subject.other | Controlled study | |
| dc.subject.other | Drug conjugation | |
| dc.subject.other | Drug potency | |
| dc.subject.other | Drug structure | |
| dc.subject.other | Drug synthesis | |
| dc.subject.other | Minimum inhibitory concentration | |
| dc.subject.other | Nonhuman | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Anti-Bacterial Agents | |
| dc.subject.other | Bacterial Proteins | |
| dc.subject.other | Berberine | |
| dc.subject.other | Enterococcus faecalis | |
| dc.subject.other | Ether, Ethyl | |
| dc.subject.other | Indoles | |
| dc.subject.other | Intercalating Agents | |
| dc.subject.other | Molecular Structure | |
| dc.subject.other | Multidrug Resistance-Associated Proteins | |
| dc.subject.other | Staphylococcus aureus | |
| dc.subject.other | Bacteria (microorganisms) | |
| dc.subject.other | Staphylococcus aureus | |
| dc.title | Antibacterial activity of berberine-NorA pump inhibitor hybrids with a methylene ether linking group | |
| dc.type | Article | |
| dspace.entity.type | Publication | |
| swu.datasource.scopus | https://www.scopus.com/inward/record.uri?eid=2-s2.0-65549100031&doi=10.1016%2fj.bmc.2009.04.028&partnerID=40&md5=7d9a30a9bf253d6997e94fd82643d982 |
